Patient Involvement in Outcome Measures for Psoriatic Arthritis

被引:34
作者
Tillett, William [1 ]
Adebajo, Ade [2 ]
Brooke, Mel
Campbell, Willemina
Coates, Laura C. [3 ,4 ]
FitzGerald, Oliver [5 ,6 ]
Gossec, Laure [7 ]
Helliwell, Philip [8 ]
Hewlett, Sarah [9 ]
James, Jana
Minnock, Patricia [10 ]
Reast, Aisling [11 ]
O'Sullivan, Dennis [5 ]
de Wit, Maarten [12 ]
McHugh, Neil [1 ,13 ]
机构
[1] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
[2] Univ Sheffield, Fac Med Dent & Hlth, Sheffield S10 2RX, S Yorkshire, England
[3] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[4] Leeds Teaching Hosp NHS Trust, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[5] St Vincents Univ Hosp, Dept Rheumatol, Dublin 4, Ireland
[6] Univ Coll Dublin, Conway Inst Biomol Res, Dublin 2, Ireland
[7] Univ Paris 06, Dept Rheumatol, Pitie Salpetriere Hosp, AP HP,GRC UPMC EEMOIS 08, Paris, France
[8] Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England
[9] Univ W England, Dept Nursing & Midwifery, Bristol BS16 1QY, Avon, England
[10] Univ Coll Dublin Rheumatol Rehabil, Our Ladys Hosp, Dublin, Ireland
[11] Pharmaceut Soc Ireland, Dublin, Ireland
[12] Vrije Univ Amsterdam Med Ctr, Dept Med Humanities, NL-1081 BT Amsterdam, Netherlands
[13] Univ Bath, Bath BA2 7AY, Avon, England
关键词
Psoriatic arthritis; Outcomemeasures; Assessment; Disease activity; Patient-reported outcomes; Patient involvement; PIOMPSA; OMERACT; QUALITY-OF-LIFE; HEALTH-ASSESSMENT QUESTIONNAIRE; COMPOSITE DISEASE-ACTIVITY; IMPACT MEASUREMENT SCALES; SPONDYLOARTHRITIS RESEARCH CONSORTIUM; INTEROBSERVER RELIABILITY EXERCISE; INFORMING RESPONSE CRITERIA; JOINT ACTIVITY INDEX; SEVERITY INDEX; RHEUMATOID-ARTHRITIS;
D O I
10.1007/s11926-014-0418-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype. There has been considerable international collaboration over recent years to develop and prioritise appropriate disease domains and outcome measures to capture all aspects of this complex disease. It has been recognised that patient-reported measures and physician assessments are complementary and, when used together, allow an improved reflection of disease burden. Taking this concept one step further, the experience in rheumatoid arthritis has demonstrated benefits of incorporating the patient perspective in the development of outcome measures. We report a systematic review demonstrating (1) that there has been little incorporation of the patient perspective in the development of outcome measures and domains in PsA, (2) the proceedings from the preliminary patient involvement in outcome measures for PsA (PIOMPSA) meetings, and (3) a proposed roadmap for improving patient involvement.
引用
收藏
页数:10
相关论文
共 77 条
[1]   Interobserver reliability of the Nail Psoriasis Severity Index [J].
Aktan, S. ;
Ilknur, T. ;
Akin, C. ;
Ozkan, S. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) :141-144
[2]  
[Anonymous], BRIEF NOT RES PUBL I
[3]   Concordant and discrepant views of patients' physical functioning [J].
Berkanovic, E ;
Hurwicz, ML ;
Lachenbruch, PA .
ARTHRITIS CARE AND RESEARCH, 1995, 8 (02) :94-101
[4]   The importance of patient participation in measuring rheumatoid arthritis flares [J].
Bingham, Clifton O., III ;
Alten, Rieke ;
de Wit, Maarten P. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (07) :1107-1109
[5]  
BLACKMORE MG, 1995, J RHEUMATOL, V22, P886
[6]   Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey [J].
Brodszky, V. ;
Pentek, M. ;
Balint, P. V. ;
Geher, P. ;
Hajdu, O. ;
Hodinka, L. ;
Horvath, G. ;
Koo, E. ;
Polgar, A. ;
Sesztak, M. ;
Szanto, S. ;
Ujfalussy, I. ;
Gulacsi, L. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 (04) :303-309
[7]   A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis [J].
Carlin, CS ;
Feldman, SR ;
Krueger, JG ;
Menter, A ;
Krueger, GG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (06) :859-866
[8]  
Cassell SE, 2007, J RHEUMATOL, V34, P123
[9]   Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study [J].
Cauli, Alberto ;
Gladman, Dafna D. ;
Mathieu, Alessandro ;
Olivieri, Ignazio ;
Porru, Giovanni ;
Tak, Paul P. ;
Sardu, Claudia ;
Ujfalussy, Ilona ;
Scarpa, Raffaele ;
Marchesoni, Antonio ;
Taylor, William J. ;
Spadaro, Antonio ;
Fernandez-Sueiro, Jose L. ;
Salvarani, Carlo ;
Kalden, Joachim R. ;
Lubrano, Ennio ;
Carneiro, Sueli ;
Desiati, Francesca ;
Flynn, John A. ;
D'Angelo, Salvatore ;
Vacca, Alessandra ;
Van Kuijk, Arno W. R. ;
Catanoso, Maria Grazia ;
Gruenke, Mathias ;
Peluso, Rosario ;
Parsons, Wendy J. ;
Ferrara, Nicola ;
Contu, Paolo ;
Helliwell, Philip S. ;
Mease, Philip J. .
JOURNAL OF RHEUMATOLOGY, 2011, 38 (05) :898-903
[10]   Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment [J].
Coates, L. C. ;
Fransen, J. ;
Helliwell, P. S. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :48-53